R

Resolve Therapeutics, LLC

2 employees

Resolve Therapeutics is focused on developing a novel approach to the treatment of Systemic Lupus Erythematosus (SLE).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Pharmaceutical

Date founded

2010

Funding rounds raised

Total raised

$5.8M

from 5 investors over 5 rounds

R

Resolve Therapeutics, LLC raised $5.8M on November 1, 2012

Investors: Washington Research Foundation, Easton Capital Investment Group and -

R

Resolve Therapeutics, LLC raised $2M on May 17, 2011

Investors: - and Easton Capital Investment Group

FAQ